NationalICMR Study To Assess Efficacy Of 4-Month Tuberculosis Treatment Regimen UnderwayBY Outlook Web Desk
NationalBiological E's Corbevax Gets DCGI Approval For Phase 2/3 Clinical Trial On Children, AdolescentsBY Outlook Web Desk
NationalPhase Three Clinical Trial Concludes 77.8 Per Cent Effectiveness Of CovaxinBY Outlook Web Desk